Meaning
High-risk medical devices that support or sustain human life are subject to the highest level of regulatory scrutiny in China. A class iii medical device holds the greatest level of risk, typically being implanted into the human body or used in life-support systems. Examples of this category include cardiac pacemakers, artificial joints, and implantable defibrillators, all of which require central government authorization.
Registration Procedure
The central National Medical Products Administration directly manages the evaluation of these complex devices. Applicants must compile detailed registration dossiers containing mechanical specifications, biocompatibility data, and sterilization validation reports. The review process is detailed and frequently requires supplementary documentation from the manufacturer.
Clinical Trial
Human clinical trials conducted within China are almost always mandatory to prove the clinical safety of these advanced systems. These studies must be performed in certified clinical trial institutions and must follow strict Good Clinical Practice guidelines. The trial data must show statistically valid safety outcomes before the regulatory body will grant approval.
Manufacturing Oversight
Factories producing these devices must adhere to stringent quality management system standards. Government inspectors conduct regular on-site audits to verify that the assembly lines, sterilization chambers, and cleanrooms maintain appropriate environmental controls. Any deviation from the approved manufacturing process can lead to the suspension of production and the recall of distributed products, which represents a major financial risk for the operating enterprise.